Thomas von Erlach, Vivtex
Thomas von Erlach
Co-Founder and Chief Scientific Officer
Vivtex

Dr. von Erlach co-founded Vivtex and joined as its Chief Scientific Officer when Vivtex was formed as a MIT spin-off in 2018. Prior to that he led the interdisciplinary efforts around gastrointestinal model systems for oral drug delivery applications in the Laboratory of Prof. Robert Langer and Prof. Giovanni Traverso, at MIT. Thomas obtained a PhD from Imperial College London in Bioengineering and BSc and MSc in Biochemistry and Biotechnology from ETH in Switzerland. His research interests include advanced in vitro model systems for drug development, oral drug delivery and gastrointestinal pharmacology. His work is published in several high impact journals including Nature Materials, Nature Biomedical Engineering and Nature Communications.